AU2001256714A1 - Water-based liquid preparation - Google Patents

Water-based liquid preparation

Info

Publication number
AU2001256714A1
AU2001256714A1 AU2001256714A AU5671401A AU2001256714A1 AU 2001256714 A1 AU2001256714 A1 AU 2001256714A1 AU 2001256714 A AU2001256714 A AU 2001256714A AU 5671401 A AU5671401 A AU 5671401A AU 2001256714 A1 AU2001256714 A1 AU 2001256714A1
Authority
AU
Australia
Prior art keywords
water
liquid preparation
based liquid
preparation
liquid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001256714A
Inventor
Takayuki Nagao
Hiroo Nitta
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kissei Pharmaceutical Co Ltd
Rohto Pharmaceutical Co Ltd
Original Assignee
Kissei Pharmaceutical Co Ltd
Rohto Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kissei Pharmaceutical Co Ltd, Rohto Pharmaceutical Co Ltd filed Critical Kissei Pharmaceutical Co Ltd
Publication of AU2001256714A1 publication Critical patent/AU2001256714A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AU2001256714A 2000-05-15 2001-05-14 Water-based liquid preparation Abandoned AU2001256714A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2000-141622 2000-05-15
JP2000141622 2000-05-15
PCT/JP2001/003976 WO2001087298A1 (en) 2000-05-15 2001-05-14 Water-based liquid preparation

Publications (1)

Publication Number Publication Date
AU2001256714A1 true AU2001256714A1 (en) 2001-11-26

Family

ID=18648710

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001256714A Abandoned AU2001256714A1 (en) 2000-05-15 2001-05-14 Water-based liquid preparation

Country Status (4)

Country Link
US (1) US6849655B2 (en)
EP (1) EP1293206A4 (en)
AU (1) AU2001256714A1 (en)
WO (1) WO2001087298A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA84694C2 (en) * 2002-12-16 2008-11-25 Киссеи Фармасьютикал Ко., Лтд. Capsule for treatment of dysuria, containing a granulated indoline compound - -adrenaline receptor blockator
AR050253A1 (en) 2004-06-24 2006-10-11 Smithkline Beecham Corp COMPOSITE DERIVED FROM INDAZOL CARBOXAMIDE, COMPOSITION THAT INCLUDES IT AND ITS USE FOR THE PREPARATION OF A MEDICINAL PRODUCT
TW200626142A (en) 2004-09-21 2006-08-01 Glaxo Group Ltd Chemical compounds
US8063071B2 (en) 2007-10-31 2011-11-22 GlaxoSmithKline, LLC Chemical compounds
US20080093247A1 (en) * 2006-10-24 2008-04-24 Alcon Manufacturing Ltd. Packaging materials for formulations containing 2-pyrrolidone derivatives
AR065804A1 (en) 2007-03-23 2009-07-01 Smithkline Beecham Corp COMPOSITE OF INDOL CARBOXAMIDE, PHARMACEUTICAL COMPOSITION THAT UNDERSTANDS IT AND USE OF THIS COMPOUND TO PREPARE A MEDICINAL PRODUCT
US8354539B2 (en) 2009-03-10 2013-01-15 Glaxo Group Limited Indole derivatives as IKK2 inhibitors
CN104211631A (en) * 2013-05-30 2014-12-17 中国科学院上海药物研究所 Indoles compound, preparation method thereof, pharmaceutical composition and application thereof
KR102206104B1 (en) * 2014-04-03 2021-01-22 한미약품 주식회사 Granule comprising silodosin, and pharmaceutical composition and formulation comprising the same

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL83086A (en) 1987-07-06 1991-03-10 Teva Pharma Stable,injectable solutions of vincristine salts
WO1991001718A1 (en) 1989-08-03 1991-02-21 Eisai Co., Ltd. Method of photostabilizing eyewash and photostabilized eyewash
US5290774A (en) 1989-08-03 1994-03-01 Eisai Co., Ltd. Photostabilizing method for ophthalmic solutions and the resulting ophthalmic solutions therefrom
US5202331A (en) * 1990-04-18 1993-04-13 Fujisawa Pharmaceutical Co., Ltd. Therapeutic agent for dysuria comprising alpha-phenyl-alpha-pyridylalkanoic acid derivatives
EP0600675B1 (en) * 1992-12-02 1998-07-08 Kissei Pharmaceutical Co., Ltd. Indoline compounds for the treatment of dysuria
JP2692535B2 (en) 1993-06-30 1997-12-17 日本電気株式会社 Solid-state imaging device for capturing strobe images
JP3331048B2 (en) * 1994-06-01 2002-10-07 キッセイ薬品工業株式会社 Indole derivatives
AU1172097A (en) 1995-12-27 1997-07-28 Rohto Pharmaceutical Co., Ltd. Pharmaceutical composition containing trehalose
JPH1029937A (en) * 1996-05-15 1998-02-03 Kobayashi Seiyaku Kogyo Kk Pharmaceutical preparation of mefenamic acid aqueous solution
JP4157988B2 (en) * 1996-07-12 2008-10-01 ロート製薬株式会社 Water-soluble preparations with no contraindications
ES2220043T3 (en) 1998-02-27 2004-12-01 Kissei Pharmaceutical Co., Ltd. DERIVATIVES OF INDOL AND MEDICINAL COMPOSITIONS CONTAINING THEM.

Also Published As

Publication number Publication date
US20030166705A1 (en) 2003-09-04
WO2001087298A1 (en) 2001-11-22
EP1293206A4 (en) 2005-09-21
US6849655B2 (en) 2005-02-01
EP1293206A1 (en) 2003-03-19

Similar Documents

Publication Publication Date Title
AU2001295657A1 (en) Formulation containing wax-esters
AU2001273423A1 (en) Liquid applicator
AU2001263839A1 (en) Liquid formulations
AU2001251275A1 (en) Liquid dispenser
AU6383901A (en) Liquid formulations
EP1151667A3 (en) Plant-activating agent
AU2002224922A1 (en) Liquid yeast compositions
AUPR045600A0 (en) Fluid devices
AU2001252971A1 (en) Tiller
AU2001248833A1 (en) Stable liquid preparation
AU2001296534A1 (en) Liquid cleaning composition
AU4852401A (en) Liquid reservoirs
AU3918501A (en) Atomiser
AU2001256714A1 (en) Water-based liquid preparation
AU2001274523A1 (en) Liquid applicator
AU2002255354A1 (en) Minoxidil-containing liquid composition
AU2001256877A1 (en) Liquid dispenser
AUPR099200A0 (en) New formulation
AU2001225166A1 (en) Liquid filter
AU4620300A (en) Can
AU2002222581A1 (en) Liquid coater
AU2002219846A1 (en) Novel use
AU2001232519A1 (en) Drawbar
AU2001274683A1 (en) Contrast agents
AU2001279721A1 (en) Structural member